Public Company News

Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types

SHANGHAI, June 1, 2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago from May 29 to June 2 (local time). As one of the world's leading oncology conferences, the ASCO Annual Meeting serves as a key venue for presenting advances in cancer r...

2026-06-01 13:51 3470

MediaTek Collaborates with NVIDIA on the RTX Spark to Power the Next Wave of Windows PC Experiences

MediaTek brings its design expertise in CPU performance and power efficiency to the groundbreaking RTX Spark, bringing local personal agents, advanced content creation, and gaming together in small, ultra-efficient Windows PCs TAIPEI, June 1, 2026 /PRNewswire/ -- MediaTek today announced its role...

2026-06-01 13:30 3018

XPENG Announces Vehicle Delivery Results for May 2026

GUANGZHOU, China, June 1, 2026 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868), a leading global AI mobility technology company, today announced its vehicle delivery results for May 2026. XPENG delivered a total of 32,158 vehicles in May, representing a 4% increas...

2026-06-01 12:47 4461

Landis+Gyr Capital Markets Day 2026

Confirms mid-term growth expectations through FY 2028, introduces new Connected Platforms and Grid Intelligence business segments and outlines financial framework CHAM, Switzerland and NEW YORK, June 1, 2026 /PRNewswire/ -- Landis+Gyr Group AG (SIX: LAND), a global energy technology leader drivi...

2026-06-01 12:45 4094

KLN Receives High Recognition in ESG Performance, Achieves Highest AAA Rating in MSCI ESG and Wins HKQAA Hong Kong Green and Sustainability Contribution Awards 2026

HONG KONG, June 1, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) is pleased to announce that its exceptional environmental, social and governance (ESG) performance has earned it an upgrade in MSCI ESG Rating to the highest tier of AAA rating. KLN is also the proud r...

2026-06-01 12:19 4923

Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou

LIUZHOU, China, June 1, 2026 /PRNewswire/ -- On May 31, the 6th LiuGong (000528.SZ) Global Customer Day was held in Liuzhou, China. Mr. Su Zimeng, President of the China Construction Machinery Association, Mr. Song Zhiping, President of the China Association for Public Companies, Mr. Zheng Jin, ...

2026-06-01 11:27 4689

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications SEOUL, South Korea, May 31, 2026 /PRNewswire/ -- Hanmi Pharm. Co., Ltd. ("Hanmi")today announced that they have entered into a license agreement for the development, manufacturing and commercialization of Hanmi's b...

2026-06-01 11:09 4117

Supermicro Launches New Server Solutions with Intel Xeon 6+ Processors to Reduce TCO and Accelerate Time-to-Online for Large-Scale Cloud and Data Centers

* 12 new systems across Hyper, SuperBlade®, FlexTwin™, and GrandTwin® families offer industry-leading core density with up to 576 efficiency cores per server * Breakthrough performance-per-watt and energy efficiency designed to lower TCO and reduce power consumption in high-density cloud and ...

2026-06-01 11:00 5319

IEI Showcases Resilient Edge AI Platforms at COMPUTEX 2026: Advancing AI Deployment Across Industrial Applications

NEW TAIPEI CITY, June 1, 2026 /PRNewswire/ -- IEI Integration Corp. (IEI) announced its COMPUTEX 2026 lineup (TaiNEX 2, Booth #P0114). Under the theme "Resilient Edge AI Platforms: T...

2026-06-01 10:12 3158

Agoda and The Trade Desk Partner to Help Brands Reach High-Intent Travelers Across APAC

Collaboration enables advertisers to engage Agoda audiences before booking decisions are made SINGAPORE, June 1, 2026 /PRNewswire/ -- Digital travel platform, Agoda and global advertising technology leader, The Trade Desk (Nasdaq: TTD) today announced a strategic partnership to enable smarter tr...

2026-06-01 10:00 3941

Mahindra and Manulife Insurance JV Moves Ahead; Gets Approval from Ministry of Corporate Affairs

Entity to be called "Mahindra Manulife Insurance Limited"; a 50:50 partnership MUMBAI and HONG KONG, June 2, 2026 /PRNewswire/ -- Mahindra and Manulife announced their partnership to create a life insurance business on November 12, 2025. Both companies have confirmed the incorporation of the JV c...

2026-06-01 09:16 5856

Investor repositioning drives shift in Asia quant markets, BofA Securities conference shows

Key points * BofA Securities hosted its second annual Asia Pacific Integrated Quant Services Senior Leadership Conference in Hong Kong, convening more than 110 senior practitioners. * Discussions highlighted a shift in Asia's quant markets, with rising allocator interest, higher trading volu...

2026-06-01 09:15 4171

Hankook's Ventus Delivers Unwavering Performance Throughout WRC FORUM8 Rally Japan's Ever-Changing Conditions

* Round 7 of the 2026 WRC unfolded across the Aichi and Gifu regions of Japan, featuring fierce competition on rugged mountain stages * Ventus Z215 and Z210 rally tires delivered stable grip and consistent performance in rapidly changing road conditions * Round 8 of the 2026 WRC season, EKO ...

2026-06-01 09:10 4059

BofA Securities Asia Forum Gathers Global Investors Amid Surge in Hedge Funds Allocations

Key points * BofA Securities hosted its fourth annual Asia Alternatives Forum, bringing together more than 20 hedge fund managers and 120 institutional allocators. * Allocators of approximately $700 billion in hedge fund capital discussed market conditions and investment strategies. * A Bof...

2026-06-01 09:00 5111

UOB and FPT sign MoU to advance AI, technology transformation and financial innovation opportunities

SINGAPORE, June 1, 2026 /PRNewswire/ -- UOB and global technology corporation FPT have signed a Memorandum of Understanding (MoU) to explore strategic collaboration opportunities in artificial intelligence (AI), digital and technology transformation, and financial services innovation.

2026-06-01 09:00 4055

Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting

SHANGHAI, May 31, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the long-term analysis results of satricabtagene autoleucel ("satri-cel", CT041) (an autologous CAR T-cell product ca...

2026-06-01 08:15 4152

ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept

First-line NSCLC – Compelling Activity Across All PD-L1 Subgroups In first-line non-small cell lung cancer (NSCLC) patients with high PD-L1 expression (TPS ≥50%), CS2009 monotherapy achieved anobjective response rate (ORR) of 81.3% and a disease control rate (DCR) of 100.0%, with consistent benef...

2026-06-01 08:15 3731

MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026

TAIPEI, June 1, 2026 /PRNewswire/ -- MICROIP (TPEx: 7796), specializing in AI software and ASIC design services, will unveil its "AI Vehicle System Business Group" at COMPUTEX 2026 (Booth A1215a, TWTC Hall 1, June 2-5). Echoing the "AI Together" theme, the showcase focuses on edge AI, smart mobil...

2026-06-01 08:00 4337

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

TAIPEI, June 1, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today highlighted a strategic vision detailed by its found...

2026-06-01 08:00 3205

2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced NSCLC

* IBI363 in combination with chemotherapy demonstrated encouraging efficacy signals and manageable safety in the first-line treatment of NSCLC with PD-L1 negative or low expression. The 3→1.5 mg/kg dose group (n=22) showed ORR of 86.4%, confirmed ORR (cORR) of 81.8% (95% CI: 59.7-94.8) and DCR ...

2026-06-01 08:00 3529
1 ... 15161718192021 ... 1667